SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced ...

SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced ...

SAN MATEO, Calif., and CAMBRIDGE, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced U ...

Preclinical data featured in three posters show potential of KB-0742 in triple-negative breast, lung and ovarian cancers, as well as lymphoma and rare, soft-tissue cancers, including sarcoma and ...

Figure 1: Myc-induced senescence in Cdk2 −/− cells. Figure 4: Pre-tumoural analysis and lymphomagenesis in Eμ-Myc Cdk2 −/− mice. Figure 5: CDK2 inhibitors trigger a Myc-dependent senescence response ...

The transcription factor Myc plays a major role in gene expression. It regulates the expression of 15 percent to 20 percent of all genes, and Myc mutations are known or suspected to be drivers in many ...

Myc-associated factor X (MAX), the protein that forms dimers with Myc, could hold the key to blocking one of the most intractable oncogenes. Scientists at the University of Chicago have designed a ...

MYC amplification found in approximately 30% of solid tumors Phase 1/2 clinical trial to begin in the first quarter of 2021 KB-0742 generated using the company’s proprietary small molecule microarray ...

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Kronos Bio NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

KB-0742 generated using the company’s proprietary small molecule microarray (SMM) screening platform SAN MATEO, Calif., and CAMBRIDGE, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Kronos ...